Literature DB >> 7865269

Incidence of apnoea and bradycardia in preterm infants following triple antigen immunization.

S J Botham1, D Isaacs.   

Abstract

Ninety-seven preterm infants were immunized with diphtheria-tetanus-pertussis (DTP) prior to discharge from hospital. The mean gestational age at birth was 28.1 weeks (range 24-34) and the mean age at immunization was 80.6 days (range 44-257). Nineteen (20%) infants developed apnoea or bradycardia within 24 h of immunization. The infants who developed apnoea and/or bradycardia had a younger gestational age at birth than those who did not (P = 0.03), were artificially ventilated for longer (P = 0.01) and were more likely to have a diagnosis of chronic lung disease (P = 0.006). In the majority of infants these events were not clinically significant. Two infants who developed concurrent upper respiratory tract infections required additional oxygen and one of them was treated with oral theophylline. In general, it is safe practice to immunize preterm infants with DTP unless otherwise contraindicated. However, it is recommended that cardiorespiratory function is monitored after immunization in very preterm infants who had prolonged ventilatory support and/or chronic lung disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865269     DOI: 10.1111/j.1440-1754.1994.tb00728.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  9 in total

1.  Severe apnoeas following immunisation in premature infants.

Authors:  M H Slack; D Schapira
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

2.  Acellular pertussis and meningococcal C vaccines: cardio-respiratory events in preterm infants.

Authors:  Martin H Slack; Christine Schapira; Richard J Thwaites; Nicholas Andrews; David Schapira
Journal:  Eur J Pediatr       Date:  2003-03-11       Impact factor: 3.183

Review 3.  Immunization of preterm infants.

Authors:  Arnaud Gagneur; Didier Pinquier; Caroline Quach
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Immunisation of premature infants.

Authors:  J Bonhoeffer; C-A Siegrist; P T Heath
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

Review 5.  Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.

Authors:  Carl T D'Angio
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  Frequency of apnea, bradycardia, and desaturations following first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B immunization in hospitalized preterm infants.

Authors:  Jackie Lee; Joan L Robinson; Donald W Spady
Journal:  BMC Pediatr       Date:  2006-06-19       Impact factor: 2.125

7.  Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants.

Authors:  Carl T D'Angio; Roy J Heyne; T Michael O'Shea; Robert L Schelonka; Seetha Shankaran; Shahnaz Duara; Ronald N Goldberg; Barbara J Stoll; Krisa P Van Meurs; Betty R Vohr; Abhik Das; Lei Li; Robert L Burton; Betty Hastings; Dale L Phelps; Pablo J Sanchez; Waldemar A Carlo; David K Stevenson; Rosemary D Higgins
Journal:  Pediatr Infect Dis J       Date:  2010-07       Impact factor: 2.129

Review 8.  Frequently asked questions on seven rare adverse events following immunization.

Authors:  G L D'alò; E Zorzoli; A Capanna; G Gervasi; E Terracciano; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2017-03

9.  Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants.

Authors:  Marissa B Wilck; Z Jin Xu; Jon E Stek; Andrew W Lee
Journal:  Hum Vaccin Immunother       Date:  2020-08-04       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.